Product NDC: | 0069-0138 |
Proprietary Name: | ALSUMA |
Non Proprietary Name: | SUMATRIPTAN |
Active Ingredient(s): | 6 mg/.5mL & nbsp; SUMATRIPTAN |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0069-0138 |
Labeler Name: | Pfizer Laboratories Div Pfizer Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022041 |
Marketing Category: | NDA |
Start Marketing Date: | 20090831 |
Package NDC: | 0069-0138-02 |
Package Description: | 2 SYRINGE, GLASS in 1 CARTON (0069-0138-02) > .55 mL in 1 SYRINGE, GLASS (0069-0138-01) |
NDC Code | 0069-0138-02 |
Proprietary Name | ALSUMA |
Package Description | 2 SYRINGE, GLASS in 1 CARTON (0069-0138-02) > .55 mL in 1 SYRINGE, GLASS (0069-0138-01) |
Product NDC | 0069-0138 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SUMATRIPTAN |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20090831 |
Marketing Category Name | NDA |
Labeler Name | Pfizer Laboratories Div Pfizer Inc |
Substance Name | SUMATRIPTAN |
Strength Number | 6 |
Strength Unit | mg/.5mL |
Pharmaceutical Classes | Serotonin 1b Receptor Agonists [MoA],Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |